Two elderly patients with mineralocorticoid excess due to 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2) impairment

Internal Medicine

Volumn 47, Issue 7, 2008, Pages 631-636

  Inada, Mitsuo ^a   Iwasaki, Keiko ^a   Imai, Chihiro ^a   Hashimoto, Satoshi ^a  

^a Kizuyabashitakeda Hospital   (Japan)

Author keywords

11 HSD2 impairment; Hypertension; Hypopotassemia; Mineralocorticoid excess; Spironolactone

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; ALDOSTERONE; CORTISONE; HYDROCORTISONE; SPIRONOLACTONE; MINERALOCORTICOID;

AGED; APPARENT MINERALOCORTICOID EXCESS SYNDROME; ARTICLE; BLOOD PRESSURE; CASE REPORT; DIARRHEA; ENZYME DEFECT; FEMALE; HUMAN; HYDROCORTISONE URINE LEVEL; VOMITING; BLOOD; METABOLIC DISORDER; URINE;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2; AGED; AGED, 80 AND OVER; ALDOSTERONE; FEMALE; HUMANS; METABOLIC DISEASES; MINERALOCORTICOID EXCESS SYNDROME, APPARENT; MINERALOCORTICOIDS;

EID: 44849128640     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.47.0563     Document Type: Article

References (16)

1. Nakaishi S, Ikehara Y, Takero S, et al. A case of NIDDM with hypopotassemia and hypertension despite low circulating levels of renin activity and aldosterone. Horumon to Rinshou 46: 122-125, 1994 (in Japanese).
2. Matsushita T, Miyahara Y, Matsushita M, et al. Liddle' syndrome in an elderly woman. Intern Med 37: 391-395, 1998.
3. Oh J, Kwon KH. Liddle's syndrome: a report in a middle-aged woman. Yonsei Med J 41: 276-280, 2000.
4. Hirayama Y, Kurai J, Doi T, et al. A case of elderly woman suspected Liddle's syndrome. Kohritsu Youkabouin Zasshi 12: 39-41, 2003 (in Japanese).
5. Inada M. An 87-year-old woman with mineralocorticoid excess due to 11β-HSD2 deficiency. Nippon Ronen Igakkai Zasshi (Japanese J Geriatrics) 44: 513-516, 2007 (in Japanese, Abstract in English).
6. Ulick S, Levine LS, Gunczler Y, et al. A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol. J Clin Endocrinol Metab 49: 757-764, 1979.
7. White FC, Mune T, Agarwal AK. 11β-hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess. Endocr Rev 18: 135-156, 1997.
8. Liddle GW, Bledsoe T, Coppage WS. A familial renal disorder simulating primary aldosteronism but with negligible aldosterone secretion. Trans Assoc Am Physicians 76: 199-213, 1963.
9. Shimkets RA, Warnock DG, Bositis CM, et al. Liddle's syndrome: heritable human hypertension caused by mutations in the β subunit of the epithelial sodium channel. Cell 79: 407-414, 1994.
10. Wilson RC, Krozowski ZS, Li K, et al. A mutation in the HSD11 B2 gene in a family with apparent mineralocorticoid excess. J Clin Endocrinol Metab 80: 2263-2266, 1995.
11. Homma K, Hasegawa T, Masumoto M, et al. Reference values for urinary steroids in japanese newborn infants: Gas chromatography/mass spectrometry in selected ion monitoring. Endocrine J 50: 783-792, 2003.
12. Hubener HJ, Fukushima DK, Gallagher TF. Substrate specificity of enzymes reducing the 11- and 20-keto groups of steroids. J Biol Chem 220: 499-511, 1956.
13. Stewart PM, Wallance AM, Valentino R, et al, Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age. The Lancet 2: 821-824, 1987.
14. Tanahashi T, Mune T, Morita H, et al. Glycyrrhizic acid suppresses type 2 11β-hydroxyteroid dehydrogenase expression in vivo. J Steroid Biochem Mol Biology 80: 441-447, 2002.
15. Inagaki K, Ohzuka F, Suzuki G, et al. A case of apparent mineral-ocorticoid excess state, induced by hypothyroidism. Nippon Naibunpi Gakkai Zasshi (Folia Endocrinol Japonica) 104, 2006 (Abstract in Japanese).
16. Best R, Walker BR. Additional value of measurement of urinary cortisone and unconjugated cortisol metabolites in assessing the activity of 11β-hydroxysteroid dehydrogenase in vivo. Clin Endocrinol 47: 231-236, 1997.